Vascular smooth muscle dysfunction and remodeling induced by ginsenoside Rg3, a bioactive component of ginseng.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Toxicological Sciences

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/toxsci/kfq201PMID 20643749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular smooth muscle dysfunction induced by monomethylarsonous acid (MMA III): a contributing factor to arsenic-associated cardiovascular diseases.

  2008cited by this paper
• U-shaped dose response in vasomotor tone: a mixed result of heterogenic response of multiple cells to xenobiotics.

  2008cited by this paper
• Cellular and molecular mechanisms regulating vascular tone. Part 1: basic mechanisms controlling cytosolic Ca2+ concentration and the Ca2+-dependent regulation of vascular tone

  2007cited by this paper
• Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks.

  2007cited by this paper
• 'First, do no harm' with complementary and alternative medicine.

  2007cited by this paper
• Use of complementary therapies in patients with cardiovascular disease.

  2006cited by this paper
• Herbal Medicines and Perioperative Care

  2006cited by this paper
• Hydrogen Peroxide as a Paracrine Vascular Mediator: Regulation and Signaling Leading to Dysfunction

  2006cited by this paper
• Effects of ginsenosides and their metabolites on voltage-dependent Ca(2+) channel subtypes.

  2006cited by this paper
• Local subplasma membrane Ca2+ signals detected by a tethered Ca2+ sensor

  2006cited by this paper
• Modulation of vascular smooth muscle signaling by reactive oxygen species.

  2006cited by this paper
• Stereospecific effects of ginsenoside Rg3 epimers on swine coronary artery contractions.

  2006cited by this paper
• Emerging role of epoxyeicosatrienoic acids in coronary vascular function

  2006cited by this paper
• Sex hormones as potential modulators of vascular function in hypertension.

  2005influential reference
• High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies.

  2005cited by this paper
• Decreased Expression of Maxi-K+ Channel β1-Subunit and Altered Vasoregulation in Hypoxia

  2005cited by this paper
• Toward functional genomics of flow-induced outward remodeling of resistance arteries.

  2005cited by this paper
• Drug-induced vascular injury--a quest for biomarkers.

  2005cited by this paper
• Store-operated calcium channels.

  2005cited by this paper
• Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review.

  2004influential reference
• L-type Voltage-Gated Ca2+ Channels Modulate Expression of Smooth Muscle Differentiation Marker Genes via a Rho Kinase/Myocardin/SRF–Dependent Mechanism

  2004cited by this paper
• Stereospecificity of ginsenoside Rg3 action on ion channels.

  2004cited by this paper
• Novel diacylglycerol kinase inhibitor selectively suppressed an U46619‐induced enhancement of mouse portal vein contraction under high glucose conditions

  2004cited by this paper
• Nitric oxide‐dependent modulation of the delayed rectifier K+ current and the L‐type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea‐pig cardiomyocytes

  2004cited by this paper
• Tuning smooth muscle contraction by molecular motors

  2003influential reference
• Elastase-Induced Suppression of Endothelin-Mediated Ca2+ Entry Mechanisms of Vascular Contraction

  2003cited by this paper
• Use of OTC and Herbal Products in Patients with Cardiovascular Disease

  2003cited by this paper
• Ginsenoside Rg3 inhibits phenylephrine‐induced vascular contraction through induction of nitric oxide synthase

  2003cited by this paper
• Analysis of 'SHENMAI' injection by HPLC/MS/MS.

  2003cited by this paper
• The risk-benefit profile of commonly used herbal therapies.

  2002cited by this paper
• Panax ginseng

  2002cited by this paper
• The RiskBenefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

  2002cited by this paper
• The Risk–Benefit Profile of Commonly Used Herbal Therapies

  2002cited by this paper
• Menadione induces endothelial dysfunction mediated by oxidative stress and arylation.

  2001cited by this paper
• Herbal medicines and perioperative care

  2001cited by this paper
• Thapsigargin inhibits angiogenesis in the rat isolated aorta: studies on the role of intracellular calcium pools.

  2001cited by this paper
• Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: Evidence for a receptor‐specific mechanism

  2001cited by this paper
• Effect of ginsenosides on voltage-dependent Ca(2+) channel subtypes in bovine chromaffin cells.

  2001cited by this paper
• Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide

  2001cited by this paper
• Apoptosis: mechanisms and clinical implications

  2000cited by this paper
• Strain-dependent vascular remodeling phenotypes in inbred mice.

  2000cited by this paper
• On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings.

  2000cited by this paper
• Improvements in Chronic Diseases With a Comprehensive Natural Medicine Approach: A Review and Case Series

  2000cited by this paper
• Arterial Remodeling: Mechanisms and Clinical Implications

  2000cited by this paper
• Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling.

  1999cited by this paper
• Use of confocal microscopy to investigate cell structure and function.

  1999cited by this paper
• Marked dissociation between intracellular Ca2+ level and contraction on exposure of rat aorta to lysophosphatidylcholine.

  1999cited by this paper
• Ginsenoside Rg3 mediates endothelium-dependent relaxation in response to ginsenosides in rat aorta: role of K+ channels.

  1999cited by this paper
• Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors.

  1998cited by this paper
• Angina pectoris caused by coronary microvascular spasm.

  1998cited by this paper
• Hypoxia and smooth muscle function: key regulatory events during metabolic stress

  1998cited by this paper
• Inhibition of membrane L-type calcium channel activity and intracellular calcium concentration by 24R, 25-dihydroxyvitamin D3 in vascular smooth muscle.

  1996cited by this paper
• Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States.

  1994cited by this paper
• Pathophysiology of the Vasculature in Hypertension

  1991cited by this paper
• Ginseng and high blood pressure.

  1980cited by this paper
• Ginseng abuse syndrome. Problems with the panacea.

  1979cited by this paper
• highlighted topics Signal Transduction in Smooth Muscle Invited Review: Mechanisms of calcium handling in smooth muscles

  year unknowncited by this paper

• How Natural Therapies Can Combat Neoplastic Disease by Targeting Key Survival Mechanisms and Signaling Pathways

  2025cites this paper
• Ginseng and "Shanghuo" (fireness): a comprehensive review from the viewpoints of TCM theory and modern science.

  2023cites this paper
• Ginseng in vascular dysfunction: A review of therapeutic potentials and molecular mechanisms

  2022cites this paper
• Herbal Medications Used to Ameliorate Cardiac Conditions.

  2021cites this paper
• Pharmacological properties of ginsenosides in inflammation-derived cancers

  2021cites this paper
• Ginsenosides in vascular remodeling: cellular and molecular mechanisms of their therapeutic action.

  2021cites this paper
• Effects of Panax ginseng and ginsenosides on oxidative stress and cardiovascular diseases: pharmacological and therapeutic roles

  2021cites this paper
• Characterization of hyperglycemia due to sub-chronic administration of red ginseng extract via comparative global proteomic analysis

  2021cites this paper
• Effects of Super-Imposed Pressure Oscillations on a Long-term Chronic Sensitized Airways Mouse Model.

  2020cites this paper
• Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension

  2020cites this paper
• Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension

  2020cites this paper
• The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: from molecular mechanisms to clinical applications.

  2020cites this paper
• Pharmacological effects of ginseng on infectious diseases

  2019cites this paper
• Mechanism of Beraprost Effects on Pulmonary Hypertension: Contribution of Cross-Binding to PGE2 Receptor 4 and Modulation of O2 Sensitive Voltage-Gated K+ Channels

  2019cites this paper
• Ginsenoside Rg3, a component of ginseng, induces pro-thrombotic activity of erythrocytes via hemolysis-associated phosphatidylserine exposure.

  2019cites this paper
• Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models

  2019cites this paper
• Ginsenoside Rg3 disrupts actin-cytoskeletal integrity leading to contractile dysfunction and apoptotic cell death in vascular smooth muscle.

  2018cites this paper
• Allergens in red ginseng extract induce the release of mediators associated with anaphylactoid reactions

  2017cites this paper
• Ginsenoside F2 induces the release of mediators associated with Anaphylactoid reactions.

  2017cites this paper
• Effects of ginseng on stress-related depression, anxiety, and the hypothalamic–pituitary–adrenal axis

  2017cites this paper
• Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases

  2017cites this paper
• Myocardial Ischemia-Reperfusion Injury: The Perioperative Application and Cardiac Protective Potential of Ginsenoside Preparations

  2016influential citation
• Anti-atherosclerotic plants which modulate the phenotype of vascular smooth muscle cells.

  2016cites this paper
• An Investigation of the Dynamic Response of Airway Smooth Muscle in Sensitized Animal Models

  2014cites this paper
• Dysfunction of vascular smooth muscle and vascular remodeling by simvastatin.

  2014cites this paper
• A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases

  2014influential citation
• Review of cases of patient risk associated with ginseng abuse and misuse

  2014cites this paper
• Effect of crude microbial enzyme pretreatment on the liberation of biological compounds and antioxidant activity of red ginseng extract

  2013cites this paper
• Ginsenoside Rg3 Reduces Lipid Accumulation with AMP-Activated Protein Kinase (AMPK) Activation in HepG2 Cells

  2012cites this paper
• Ginsenoside Rg 3 Reduces Lipid Accumulation with AMP-Activated Protein Kinase ( AMPK ) Activation in HepG 2 Cells

  2012cites this paper
• Sources and possible mechanisms of action of important phytoconstituents with cardiovascular properties

  2012cites this paper
• American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathway.

  2012cites this paper
• Procoagulant and prothrombotic effects of the herbal medicine, Dipsacus asper and its active ingredient, dipsacus saponin C, on human platelets

  2012cites this paper
• Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical Applications

  2012cites this paper
• Review of Red Ginseng in terms of Mechanisms for Pharmacodynamics and Toxicity

  2012cites this paper
• Potentiation of vasoconstriction and pressor response by low concentration of monomethylarsonous acid (MMA(III)).

  2011cites this paper
• Therapeutic Potential of Ginseng in the Management of Cardiovascular Disorders

  2011cites this paper